Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

1,020 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
A phase I-II preoperative biomarker trial of fenretinide in ascitic ovarian cancer.
Colombo N, Formelli F, Cantù MG, Parma G, Gasco M, Argusti A, Santinelli A, Montironi R, Cavadini E, Baglietto L, Guerrieri-Gonzaga A, Viale G, Decensi A. Colombo N, et al. Among authors: montironi r. Cancer Epidemiol Biomarkers Prev. 2006 Oct;15(10):1914-9. doi: 10.1158/1055-9965.EPI-06-0183. Cancer Epidemiol Biomarkers Prev. 2006. PMID: 17035399 Clinical Trial.
Phase I-II trial of weekly bicalutamide in men with elevated prostate-specific antigen and negative prostate biopsies.
Zanardi S, Puntoni M, Maffezzini M, Bandelloni R, Mori M, Argusti A, Campodonico F, Turbino L, Branchi D, Montironi R, Decensi A. Zanardi S, et al. Among authors: montironi r. Cancer Prev Res (Phila). 2009 Apr;2(4):377-84. doi: 10.1158/1940-6207.CAPR-08-0205. Epub 2009 Mar 31. Cancer Prev Res (Phila). 2009. PMID: 19336728 Free article. Clinical Trial.
Strong immunohistochemical expression of fibroblast growth factor receptor 3, superficial staining pattern of cytokeratin 20, and low proliferative activity define those papillary urothelial neoplasms of low malignant potential that do not recur.
Barbisan F, Santinelli A, Mazzucchelli R, Lopez-Beltran A, Cheng L, Scarpelli M, van der Kwast T, Montironi R. Barbisan F, et al. Among authors: montironi r. Cancer. 2008 Feb 1;112(3):636-44. doi: 10.1002/cncr.23212. Cancer. 2008. PMID: 18072261 Free article.
HER2 expression and gene amplification in pT2a Gleason score 6 prostate cancer incidentally detected in cystoprostatectomies: comparison with clinically detected androgen-dependent and androgen-independent cancer.
Montironi R, Mazzucchelli R, Barbisan F, Stramazzotti D, Santinelli A, Scarpelli M, Lòpez Beltran A. Montironi R, et al. Hum Pathol. 2006 Sep;37(9):1137-44. doi: 10.1016/j.humpath.2006.04.004. Epub 2006 Jun 21. Hum Pathol. 2006. PMID: 16938518
Immunohistochemical expression of prostate tumor overexpressed 1 in cystoprostatectomies with incidental and insignificant prostate cancer. Further evidence for field effect in prostatic carcinogenesis.
Mazzucchelli R, Barbisan F, Santinelli A, Lopez-Beltran A, Cheng L, Scarpelli M, Montironi R. Mazzucchelli R, et al. Among authors: montironi r. Hum Pathol. 2011 Dec;42(12):1931-6. doi: 10.1016/j.humpath.2011.02.014. Epub 2011 Jun 14. Hum Pathol. 2011. PMID: 21676431
1,020 results